Avinger Inc financial data

Symbol
AVGR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
400 Chesapeake Drive, Redwood City, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 85.2 % -25.3%
Quick Ratio 29.3 % -4.22%
Debt-to-equity -1.81K % -121%
Return On Equity 2.01K %
Return On Assets -118 % -54.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.3M shares -78.8%
Common Stock, Shares, Outstanding 1.92M shares -79.5%
Entity Public Float 6.8M USD -22.7%
Common Stock, Value, Issued 2K USD -77.8%
Weighted Average Number of Shares Outstanding, Basic 1.63M shares +168%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 5.95M USD +8.74%
Research and Development Expense 4.16M USD -9.05%
Operating Income (Loss) -17.9M USD -15.3%
Net Income (Loss) Attributable to Parent -19.4M USD -13.4%
Earnings Per Share, Basic -9.06 USD/shares +88.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.81M USD +23.6%
Accounts Receivable, after Allowance for Credit Loss, Current 931K USD +1.2%
Inventory, Net 4.12M USD -25.3%
Assets, Current 14.9M USD +3.07%
Property, Plant and Equipment, Net 455K USD -19.6%
Operating Lease, Right-of-Use Asset 1.71M USD +3.2%
Other Assets, Noncurrent 229K USD -12.9%
Assets 17.3M USD +2.08%
Accounts Payable, Current 725K USD +71.4%
Employee-related Liabilities, Current 1.94M USD -21.6%
Accrued Liabilities, Current 804K USD +6.49%
Liabilities, Current 9M USD -59.9%
Operating Lease, Liability, Noncurrent 528K USD +3.94%
Other Liabilities, Noncurrent 12K USD -97.9%
Liabilities 9.54M USD -59.5%
Retained Earnings (Accumulated Deficit) -431M USD -4.71%
Stockholders' Equity Attributable to Parent 7.75M USD
Liabilities and Equity 17.3M USD +2.08%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.73M USD -12.4%
Net Cash Provided by (Used in) Financing Activities 6.63M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.92M shares -79.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.9M USD
Deferred Tax Assets, Valuation Allowance 99.4M USD +3.51%
Deferred Tax Assets, Gross 99.6M USD +3.19%
Operating Lease, Liability 1.71M USD +3.2%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 1.79M USD +2.76%
Property, Plant and Equipment, Gross 4.59M USD -1.37%
Operating Lease, Liability, Current 1.18M USD +2.87%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 623K USD -45.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 78K USD -6.02%
Deferred Tax Assets, Operating Loss Carryforwards 87.6M USD +2.36%
Preferred Stock, Shares Issued 30.2K shares -50.4%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.68M USD +3.8%
Preferred Stock, Shares Outstanding 30.2K shares -50.4%
Depreciation, Depletion and Amortization 83K USD +15.3%
Deferred Tax Assets, Net of Valuation Allowance 278K USD -50.4%
Share-based Payment Arrangement, Expense 1.76M USD +236%
Interest Expense 1.53M USD -5.61%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%